Behavioral Activation Therapy for Depression

Acceptance and Commitment Therapy

Justification not yet generated — showing supporting facts

• In both Acceptance and Commitment Therapy (ACT) and Behavioral Activation Treatment for Depression (BATD), improvements in pain interference at follow-up were significantly mediated by improvements at post-treatment in psychological flexibility (Sanabria-Mazo et al., 2023).
• There were no significant differences between Behavioral Activation Therapy for Depression (BATD) and Treatment as Usual (TAU), or between Acceptance and Commitment Therapy (ACT) and Treatment as Usual (TAU), in the improvement of depressive, anxiety, and stress symptoms.
• There were no significant differences in psychological flexibility between Acceptance and Commitment Therapy (ACT) and Behavioral Activation Treatment for Depression (BATD).
• Including remote synchronous video group-based Acceptance and Commitment Therapy (ACT) or Behavioral Activation Treatment for Depression (BATD) as adjuncts to Treatment As Usual (TAU) provides clinical utility for improving pain interference and pain catastrophizing in patients with chronic low back pain (CLBP) and comorbid depressive symptoms.
• The systematic review examined the efficacy of Cognitive Behavioral Therapy (nine studies), Mindfulness-based Interventions (three studies), Acceptance and Commitment Therapy (one study), and Behavioral Activation Therapy for Depression (one study).
• A study by Sanabria-Mazo et al. (2023) conducted a randomized controlled trial (the IMPACT study) evaluating the efficacy of videoconference group Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD) for patients with chronic low back pain and comorbid depressive symptoms.
• No significant differences were found between Acceptance and Commitment Therapy (ACT) and Treatment as Usual (TAU), between Behavioral Activation Therapy for Depression (BATD) and Treatment as Usual (TAU), or between ACT and BATD regarding pain intensity.
• In the Sanabria-Mazo et al. (2023) study, the ACT and BATD interventions were delivered by trained clinical psychologists in 8 sessions lasting 90 minutes each.
• Patients assigned to Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD) reported a significant reduction in pain catastrophizing compared to Treatment as Usual (TAU) at post-treatment (ACT effect size d = 0.45; BATD effect size d = 0.59) and at follow-up (both effect sizes d = 0.59).
• More randomized controlled trials (RCTs) based on Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Treatment for Depression (BATD) are needed to determine the overall efficacy of these interventions for patients with comorbid chronic pain and psychological distress.
• Mindfulness-based Interventions (MBI), Dialectical Behavior Therapy (DBT), Rational Emotive Behavior Therapy (REBT), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Therapy for Depression (BATD) produce positive effects in patients with chronic pain, according to research by Jorn (2015), Veehof et al. (2016), Hughes et al. (2017), Boersma et al. (2019), Khoo et al. (2019), Gloster et al. (2020), and Pardos-Gascón et al. (2021).
• The systematic review organized information from controlled trials according to the type of intervention, specifically Cognitive Behavioral Therapy (CBT), Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Treatment for Depression (BATD).
• Research interest is increasing in how CBT-based therapies, including Cognitive Behavioral Therapy (CBT), Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Treatment for Depression (BATD), can improve the functional status and quality of life in patients with chronic pain experiencing depressive and/or anxiety symptoms.
• The systematic review synthesized findings by categorizing them into four therapy types: Cognitive Behavioral Therapy (CBT), Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), and Behavioral Activation Treatment for Depression (BATD).
• Sanabria-Mazo et al. (2023) conducted a randomized controlled trial in Spain involving patients with chronic low back pain (CLBP) and depression, comparing Acceptance and Commitment Therapy plus Treatment as Usual (ACT+TAU), Behavioral Activation Therapy plus Treatment as Usual (BATD+TAU), and Treatment as Usual (TAU) alone.
• Table 4 in the systematic review provides a synthesis of evidence comparing Cognitive Behavioral Therapy (CBT), Mindfulness-Based Interventions (MBI), Acceptance and Commitment Therapy (ACT), or Behavioral Activation Treatment for Depression (BATD) against Treatment as Usual (TAU).
• The IMPACT study protocol, published by Sanabria-Mazo et al. (2020), outlines a randomized controlled trial to assess the efficacy, cost-utility, and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioral Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression, utilizing mobile-technology-based ecological momentary assessment.
• No significant differences were found between Behavioral Activation Therapy for Depression (BATD) and Treatment as Usual (TAU), or between Acceptance and Commitment Therapy (ACT) and BATD, regarding pain acceptance.
• There were no significant differences in behavioral activation between Acceptance and Commitment Therapy (ACT) and Behavioral Activation Treatment for Depression (BATD).
• No significant differences in depressive or anxiety symptoms were found in Acceptance and Commitment Therapy (ACT) and Behavioral Activation Treatment for Depression (BATD) compared to Treatment As Usual (TAU) at any assessment time points.
• The therapeutic interventions analyzed in the 13 studies included in the systematic review were: Cognitive Behavioral Therapy (69%), Mindfulness-Based Interventions (23%), and Acceptance and Commitment Therapy and Behavioral Activation Treatment for Depression (8%).
• A study by Sanabria-Mazo et al. (2023) evaluated the efficacy of Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD) compared to Treatment as Usual (TAU), using an intention-to-treat (ITT) analysis with pre-, post-, and follow-up assessments, focusing on pain interference as the primary outcome.

cognitive-behavioral therapy

Cognitive Behavioral Therapy and Behavioral Activation Therapy for Depression are related as they are both categorized as therapeutic interventions within the same systematic review [1], [2]. They are frequently compared and synthesized together in research studies evaluating their efficacy against treatment as usual [3], [4], [5] and their potential to improve patient quality of life [6]. — 6 supporting facts

chronic pain

Behavioral Activation Therapy for Depression is identified as an intervention that produces positive effects in patients with chronic pain [1] and is a subject of research regarding its efficacy for patients suffering from comorbid chronic pain [2], as part of a broader investigation into CBT-based therapies [3]. — 3 supporting facts